Targacept/GSK’s Nicotinic Receptor Modulator Fails Phase II Pain Study
Experimental pain killer performed no better than placebo, failing a proof-of-concept study for post-operative pain.
Experimental pain killer performed no better than placebo, failing a proof-of-concept study for post-operative pain.